These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 35877992

  • 1. Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
    Barnes RFW, Pandey B, Sun HL, Jackson S, Kruse-Jarres R, Quon DV, von Drygalski A.
    Haemophilia; 2022 Nov; 28(6):e228-e236. PubMed ID: 35877992
    [Abstract] [Full Text] [Related]

  • 2. Risk of diabetes in haemophilia patients compared to clinic and non-clinic control cohorts.
    Pandey B, Barnes RFW, Sun HL, Jackson S, Kruse-Jarres R, Quon DV, von Drygalski A.
    Haemophilia; 2022 May; 28(3):445-452. PubMed ID: 35238443
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors.
    Ter-Zakarian A, Barnes RFW, Kruse-Jarres R, Quon DV, Jackson S, Sun HL, von Drygalski A.
    Haemophilia; 2022 Nov; 28(6):977-985. PubMed ID: 35768896
    [Abstract] [Full Text] [Related]

  • 4. Renal disease among males with haemophilia.
    Kulkarni R, Soucie JM, Evatt B, Hemophilia Surveillance System Project Investigators.
    Haemophilia; 2003 Nov; 9(6):703-10. PubMed ID: 14750936
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or B.
    Husseinzadeh H, Chiasakul T, Gimotty PA, Pukenas B, Wolf R, Kelty M, Chiang E, Fogarty PF, Cuker A.
    Haemophilia; 2018 Mar; 24(2):271-277. PubMed ID: 29282815
    [Abstract] [Full Text] [Related]

  • 6. Risk assessment for coronary heart disease in patients with haemophilia: a single centre study in the United States.
    Sait AS, Kuo A, Bettencourt R, Bergstrom J, Allison M, von Drygalski A.
    Haemophilia; 2014 Nov; 20(6):763-70. PubMed ID: 24893625
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand.
    Thitipatarakorn S, Chinbunchorn T, Peelay J, Seekaew P, Amatavete S, Sangsai M, Pankam T, Avihingsanon A, Avery M, Phanuphak P, Ramautarsing R, Phanuphak N.
    BMC Public Health; 2022 Jan 20; 22(1):144. PubMed ID: 35057784
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and risk factors for hypertension in hemophilia.
    von Drygalski A, Kolaitis NA, Bettencourt R, Bergstrom J, Kruse-Jarres R, Quon DV, Wassel C, Li MC, Waalen J, Elias DJ, Mosnier LO, Allison M.
    Hypertension; 2013 Jul 20; 62(1):209-15. PubMed ID: 23630949
    [Abstract] [Full Text] [Related]

  • 9. A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.
    Brar I, Shuter J, Thomas A, Daniels E, Absalon J, Minorities and Women's Task Force of Terry Beirn Community Programs for Clinical Research on AIDS.
    J Acquir Immune Defic Syndr; 2007 May 01; 45(1):66-71. PubMed ID: 17245229
    [Abstract] [Full Text] [Related]

  • 10. Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection.
    Jeudy J, Patel P, George N, Burrowes S, Husson J, Chua J, Conn L, Weiss RG, Bagchi S.
    AIDS; 2022 Mar 01; 36(3):399-407. PubMed ID: 34750294
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.
    Bräu N, Bini EJ, Shahidi A, Aytaman A, Xiao P, Stancic S, Eng R, Brown ST, Paronetto F.
    Am J Gastroenterol; 2002 Aug 01; 97(8):2071-8. PubMed ID: 12190179
    [Abstract] [Full Text] [Related]

  • 12. Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
    Nagao A, Suzuki N, Takedani H, Yamasaki N, Chikasawa Y, Sawada A, Kanematsu T, Nojima M, Higasa S, Amano K, Fukutake K, Fujii T, Matsushita T, Suzuki T.
    Haemophilia; 2019 Jul 01; 25(4):e223-e230. PubMed ID: 31045306
    [Abstract] [Full Text] [Related]

  • 13. Management of comorbidities in haemophilia.
    Kempton CL, Makris M, Holme PA.
    Haemophilia; 2021 Feb 01; 27 Suppl 3():37-45. PubMed ID: 32476243
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
    Sharathkumar AA, Soucie JM, Trawinski B, Greist A, Shapiro AD.
    Haemophilia; 2011 Jul 01; 17(4):597-604. PubMed ID: 21323799
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors associated with hepatitis C among Brazilian male patients with haemophilia: A long-term follow-up.
    Carmo RA, Martins ML, Chaves DG, Dezanet LNC.
    Haemophilia; 2019 May 01; 25(3):447-455. PubMed ID: 30866172
    [Abstract] [Full Text] [Related]

  • 16. Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies.
    Trickey A, Ingle SM, Boyd A, Gill MJ, Grabar S, Jarrin I, Obel N, Touloumi G, Zangerle R, Rauch A, Rentsch CT, Satre DD, Silverberg MJ, Bonnet F, Guest J, Burkholder G, Crane H, Teira R, Berenguer J, Wyen C, Abgrall S, Hessamfar M, Reiss P, d'Arminio Monforte A, McGinnis KA, Sterne JAC, Wittkop L, Antiretroviral Therapy Cohort Collaboration.
    J Viral Hepat; 2023 Sep 01; 30(9):775-786. PubMed ID: 37338017
    [Abstract] [Full Text] [Related]

  • 17. Hypertension and cardiovascular diseases in Swedish persons with haemophilia - A longitudinal registry study.
    Lövdahl S, Henriksson KM, Baghaei F, Holmström M, Berntorp E, Astermark J.
    Thromb Res; 2019 Sep 01; 181():106-111. PubMed ID: 31386935
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
    Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP.
    Haemophilia; 2005 May 01; 11(3):270-5. PubMed ID: 15876273
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry.
    Rejtő J, Reitter-Pfoertner S, Kepa S, Feistritzer C, Grundbichler M, Hörbst A, Jones N, Muntean W, Neumeister P, Oberbichler S, Schuster G, Schwarz R, Thom K, Zwiauer K, Streif W, Male C, Pabinger I.
    Hamostaseologie; 2019 Aug 01; 39(3):284-293. PubMed ID: 30419589
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia.
    Yıldız M, Özdemir N, Önal H, Koç B, Eliuz Tipici B, Zülfikar B.
    J Clin Res Pediatr Endocrinol; 2019 May 28; 11(2):173-180. PubMed ID: 30582317
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.